|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0025241,
umls-concept:C0026764,
umls-concept:C0030705,
umls-concept:C0032952,
umls-concept:C0039736,
umls-concept:C0442027,
umls-concept:C1707455,
umls-concept:C2587213
|
|
pubmed:issue |
9513
|
|
pubmed:dateCreated |
2006-3-13
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Since 1960, oral melphalan and prednisone (MP) has been regarded as the standard of care in elderly multiple myeloma patients. This multicentre randomised trial compared oral MP plus thalidomide (MPT) with MP alone in patients aged 60-85 years.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:AmbrosiniMaria TeresaMT,
pubmed-author:AvontoIlariaI,
pubmed-author:BoccadoroMarioM,
pubmed-author:BringhenSaraS,
pubmed-author:CalleaVincenzoV,
pubmed-author:CangialosiClotildeC,
pubmed-author:CapparellaVincenzoV,
pubmed-author:CaravitaTommasoT,
pubmed-author:CatalanoLucioL,
pubmed-author:CeccarelliManuelaM,
pubmed-author:CicconeGiovanninoG,
pubmed-author:De StefanoValerioV,
pubmed-author:FalcoPatriziaP,
pubmed-author:GalliMonicaM,
pubmed-author:GrassoMariellaM,
pubmed-author:LiberatiAnna MarinaAM,
pubmed-author:MerlaEmanuelaE,
pubmed-author:MustoPellegrinoP,
pubmed-author:PalumboAntonioA,
pubmed-author:PetrucciMaria TeresaMT,
pubmed-author:RossiniFaustoF,
pubmed-author:ZamagniElenaE,
pubmed-author:ZirnT TTT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
11
|
|
pubmed:volume |
367
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
825-31
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16530576-Aged,
pubmed-meshheading:16530576-Aged, 80 and over,
pubmed-meshheading:16530576-Antineoplastic Agents, Alkylating,
pubmed-meshheading:16530576-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16530576-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16530576-Disease-Free Survival,
pubmed-meshheading:16530576-Female,
pubmed-meshheading:16530576-Humans,
pubmed-meshheading:16530576-Male,
pubmed-meshheading:16530576-Melphalan,
pubmed-meshheading:16530576-Middle Aged,
pubmed-meshheading:16530576-Multiple Myeloma,
pubmed-meshheading:16530576-Prednisone,
pubmed-meshheading:16530576-Thalidomide
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
|
|
pubmed:affiliation |
Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S Giovanni Battista, 10126 Torino, Italy. appalumbo@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
